Episode
Food coloring additives & T2D, automated insulin delivery systems in T2D, and more!
- Podcast
- DOC Updates
- Published
- Jun 2, 2026
- Duration seconds
- 2321
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/doc-updates-200053/episodes/food-coloring-additives-t2d-automated-insulin-delivery-systems-in-t2d-and-more/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/doc-updates-200053/food-coloring-additives-t2d-automated-insulin-delivery-systems-in-t2d-and-more.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Welcome to the latest episode (June 2026) of Diabetes Core Update , where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic disease. This month on DOC Update : Shah S, et al. " Food Coloring Additives and Incidence of Type 2 Diabetes in the NutriNet-Santé Prospective Cohort Diabetes Care . 2026;49(6):1067–1077. doi.org/10.2337/dc25-2727 Hespanhol L, et al. " Automated Insulin Delivery Systems in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis ." Diabetes Care . 2026;49(6):1134–1143. doi.org/10.2337/dc25-2435 Tatum K, et al. " Survival and Recurrence With GLP-1 Receptor Agonists in Breast Cancer ." JAMA . Published Online: May 11, 2026 2026;9;(5):e2612133. doi:10.1001/jamanetworkopen.2026.12133 Winkler C, et al. " Screening Children for Early-Stage Type 1 Diabetes ." JAMA . Published Online: May 21, 2026 doi:10.1001/jama.2026.6085 Würtz Yazdanfard P, Kosjerina V, Wood-Kurland H et al. " Effectiveness and Safety of Semaglutide in Type 1 Diabetes: A Danish Nationwide Cohort Study (2018–2024) " Lancet . Volume 66, 101716, July 2026. doi:10.1016/j.lanepe.2026.101716 Horn D, Aronne L, Wharton S et al. " Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial ." Lancet . Published online May 12, 2026. doi:10.1016/S0140-6736(26)00656-2 Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson Univers…